Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1995/12/01 by José Mayordomo, J.I. Mayordomo, T. Zorina +18 · 2 citations
Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine · #Cancer Immunotherapy and Biomarkers #Immunotherapy and Immune Responses #vaccines and immunoinformatics approaches

paper · doi:10.1038/nm1295-1297

crossref issued 1995/12/01 · crossref published 1995/12/01 · crossref published-print 1995/12/01 · openalex publication_date 1995/12/01 · crossref created 2004/08/19 · crossref deposited 2023/05/18 · openalex created_date 2025/10/10 · crossref indexed 2026/05/21 · openalex updated_date 2026/08/01

Citations

• B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells.
• Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells

Cited by

• Alphavirus vectors for cancer therapy
• Cancer vaccine targeting CD4+ T cells [wikipedia]